Clinical signs, neurophysiological evaluation, and medication of spasticity - Review

Brain and Nerve

Volumn 60, Issue 12, 2008, Pages 1409-1414

  Matsumoto, Hideyuki ^a   Ugawa, Yoshikazu ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Corticospinal tract; H reflex; Magnetic stimulation; Spasticity; Stretch reflex

Indexed keywords

AFLOQUALONE; BACLOFEN; DANTROLENE; DIAZEPAM; EPERISONE; TIZANIDINE;

BABINSKI REFLEX; BRAIN STEM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DYSTONIA; ELECTROMYOGRAPHY; HOFFMANN REFLEX; HUMAN; HYPERREFLEXIA; JOINT CONTRACTURE; MAGNETIC STIMULATION; MUSCLE RIGIDITY; MUSCLE STIFFNESS; MUSCLE TONE; MYOTATIC REFLEX; NERVE STIMULATION; NERVE TRACT; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; PARALYSIS; PASSIVE MOVEMENT; PATHOPHYSIOLOGY; PYRAMIDAL TRACT; REVIEW; SPASTICITY; SPINAL ROOT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

H-REFLEX; HUMANS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PYRAMIDAL TRACTS; REFLEX, STRETCH; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 57749202929     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Kennard MA, Fulton JF: The localizing significance of spasticity, reflex grasping and the signs of Babinski and Rossolimo. Brain 56: 213-225, 1933
2. Fulton JF: A note on the definition of the motor and premotor areas. Brain 57: 311-316, 1934
3. Davidoff RA: The pyramidal tract. Neurology 40: 332-339, 1990
4. Laplane D, Talairach J, Meininger V, Bancaud J, Bouchareine A: Motor consequences of motor area ablations in man. J Neurol Sci 31: 29-49, 1977
5. Lance JW: Symposium synopsis. In Spasticity: Disordered Motor Control, Feldman RG, Yong R, Koella W (eds), Year Book Medical Publishers, Chicago, 1980, pp485-494
6. Clin Neurosci 26: 583, 2008
7. Clin Neurosci 25: 1198-1201, 2007
8. Japanese source
9. Dietz V, Sinkjaer T: Spastic movement disorder: impared reflex function and altered muscle mechanics. Lancet Neurol 6: 725-733, 2007
10. Atkinson PP, Atkinson JL: Spinal shock. Mayo Clin Proc 71: 384-389, 1996
11. Little JW, Ditunno JF Jr, Stiens SA, Harris RM: Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch Phys Med Rehabil 80: 587-599, 1999
12. Japanese source
13. Clin Neurosci 20:1276-1279, 2002
14. Brain Medical 20: 283-289, 2008
15. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192: 540-542, 1964
16. Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207, 1987
17. Yanagisawa N, Shindo M, Morita H, Yanagawa S: Methodological problems in the Hoffmann reflex study of spasticity. In Spasticity: Mechanisms and Management, Thilmann AF, Burke DJ, Rymer WZ (eds), Springer-Verlag, Berlin, 1993, pp273-286
18. Ugawa Y: Stimulation at the foramen magnum level as a tool to separate cortical from spinal cord excitability changes. Adv Clin Neurophysiol (Suppl Clin Neurophysiol) 54: S216-222, 2002
19. Terao Y, Ugawa Y: Basic mechanisms of TMS. J Clin Neurophysiol 19: 322-343, 2002
20. Japanese source
21. Sartucci F, Tovani S, Murri L, Sagliocco L: Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4. Brain Res Bull 74: 243-249, 2007
22. Uozumi T, Ito Y, Tsuji S, Murai Y: Inhibitory period following motor potentials evoked by magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol 85: 273-279, 1992
23. Nielsen JE, Jennum P, Fenger K, Sorensen SA, Fuglsang-Frederiksen A: Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p. Eur J Neurol 8: 335-339, 2001
24. Japanese source
25. Abbruzzese G: The medical management of spasticity. Eur J Neurol 9 (Supple 1): S30-34, 2002
26. Lataste X, Emre M, Davis C, Groves L: Comparative profile of tizanidine in the management of spasticity. Neurology 44: S53-59, 1994
27. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM: Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Supple 6: S92-120, 1997
28. Watanabe T: The role of therapy in spasticity management. Am J Phys Med Rehabil 83 (Suppl 10): S45-49, 2004